Table 2 Baseline characteristics and clinical data of patients with idiopathic membranous nephropathy at the time of renal biopsy*
Characteristic | IMN patients*(n = 67) | No Thromboembolic events (n = 53) | Thromboembolic events (n = 14) | P-value |
|---|---|---|---|---|
Age (years) | 58.3 ± 16.7 | 58.6 ± 16.7 | 57.3 ± 17.4 | NS |
Sex, male,n (%) | 42 (63%) | 38 (73%) | 11 (78.5%) | NS |
Ethnicity, n (%) | ||||
Caucasians | 39 (59%) | 31 (60%) | 8 (58%) | NS |
Afro-Carribeans | 11 (16%) | 09 (17%) | 2 (14%) | NS |
South Asians | 09 (13%) | 07 (14%) | 2 (14%) | NS |
Middle-East | 08 (12%) | 05 (09%) | 2 (14%) | NS |
Duration of follow-up (years) | 7.2 ± 3 | 7.1 ± 3 | 7.8 ± 3.2 | NS |
s.creatinine (mg/dl) | 1.24 ± 0.8 | 1.23 ± 0.7 | 1.28 ± 0.8 | NS |
s.albumin (g/dl) | 2.3 ± 0.4 | 2.4 ± 0.4 | 1.9 ± 0.5 | < 0.01 |
s.cholesterol (mg/dl) | 336 ± 128 | 317 ± 108 | 414 ± 124 | 0.01 |
eGFR (ml/min per 1.73 m2) | 65 ± 27 | 66 ± 25 | 62 ± 29 | NS |
Proteinuria (g/24 h) | 7.9 ± 3.5 | 7.1 ± 4 | 10.7 ± 3 | <0.01 |
Immuno-suppresion | 49 (73.1%) | 35 (66%) | 12 (86%) |